Yasunari Kashihara
Director/Board Member at ONCOLYS BIOPHARMA INC.
Net worth: 480 798 $ as of 30/05/2024
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Keiji Yoshimura | M | 68 |
Oncolys USA, Inc.
| 8 years |
Yasuo Urata | M | 68 |
Oncolys USA, Inc.
| 20 years |
Daniel Katzman | M | - |
Unleash Immuno Oncolytics, Inc.
Unleash Immuno Oncolytics, Inc. BiotechnologyHealth Technology Unleash Immuno Oncolytics, Inc. develops oncolytic virus immunotherapy products to treat cancer. Its product is UIO-512. the company is headquartered in Saint Louis, MO. | - |
Kohei Hata | M | - | 5 years | |
Yasushi Saito | M | - | 2 years | |
Charlie Bolten | M | - |
Unleash Immuno Oncolytics, Inc.
Unleash Immuno Oncolytics, Inc. BiotechnologyHealth Technology Unleash Immuno Oncolytics, Inc. develops oncolytic virus immunotherapy products to treat cancer. Its product is UIO-512. the company is headquartered in Saint Louis, MO. | - |
Naoko Iino | F | 64 | 1 years | |
Lisandro Bril | M | - |
Unleash Immuno Oncolytics, Inc.
Unleash Immuno Oncolytics, Inc. BiotechnologyHealth Technology Unleash Immuno Oncolytics, Inc. develops oncolytic virus immunotherapy products to treat cancer. Its product is UIO-512. the company is headquartered in Saint Louis, MO. | - |
Katsufusa Tachiya | M | 73 | 13 years | |
Bradford Young | M | - |
Liquid Biotech USA, Inc.
Liquid Biotech USA, Inc. Medical/Nursing ServicesHealth Services Liquid Biotech USA, Inc. provides cancer diagnosing services. The private company is based in Philadelphia, PA. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Takashi Kamitani | M | - | 2 years | |
Fumio Urano | M | 81 | - | |
Mark Cruise | M | 53 |
Trinity College Dublin
| 3 years |
Simon Hollingsworth | M | - |
Trinity College Dublin
| 4 years |
Laura McCoy | F | - |
Trinity College Dublin
| 4 years |
Simon English | M | - |
Trinity College Dublin
| 4 years |
John Jeffery | M | - |
Trinity College Dublin
| 4 years |
Jeanette Delehanty | F | - |
Trinity College Dublin
| 4 years |
Lara Alice Pender | F | - |
Trinity College Dublin
| 4 years |
Philip O'Reilly molten | M | - |
Trinity College Dublin
| 4 years |
Rebecca Glenapp | F | - |
Trinity College Dublin
| 4 years |
Louis J. Cantolupo | M | - |
Unleash Immuno Oncolytics, Inc.
Unleash Immuno Oncolytics, Inc. BiotechnologyHealth Technology Unleash Immuno Oncolytics, Inc. develops oncolytic virus immunotherapy products to treat cancer. Its product is UIO-512. the company is headquartered in Saint Louis, MO. | 3 years |
David Hourihane | M | - |
Trinity College Dublin
| 4 years |
Brian Hastings | M | - |
Trinity College Dublin
| 4 years |
John Brian Aylward | M | 45 |
Trinity College Dublin
| 4 years |
Michelle Dervan | F | - |
Trinity College Dublin
| 4 years |
Naoki Kobayashi | M | 60 | 2 years | |
Thomas Cooney | M | 60 |
Trinity College Dublin
| 3 years |
Philip Michael Brides | M | - |
Trinity College Dublin
| 4 years |
Gareth Stenson | M | - |
Trinity College Dublin
| 4 years |
Darragh Curran | M | - |
Trinity College Dublin
| 4 years |
Eoghan McCabe | M | 40 |
Trinity College Dublin
| 4 years |
Cronan McNamara | M | - |
Trinity College Dublin
| 4 years |
Pascal Casavecchia | M | - |
Trinity College Dublin
| 1 years |
Takashi Morimoto | M | 79 | - | |
Phil Byrne | M | - |
Trinity College Dublin
| 4 years |
Stephanie Jepsen | F | - |
Trinity College Dublin
| 1 years |
John Thomas Malone | M | - |
Trinity College Dublin
| 2 years |
Conor Martin | M | - |
Trinity College Dublin
| 1 years |
Noel Sullivan | M | - |
Trinity College Dublin
| 4 years |
Alexandra Lemacon | F | - |
Trinity College Dublin
| 1 years |
Statistics
Country | Connections | % of total |
---|---|---|
Ireland | 26 | 63.41% |
Japan | 10 | 24.39% |
United States | 7 | 17.07% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Yasunari Kashihara
- Personal Network